Literature DB >> 1582885

Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG.

T Kataoka1, S Yamamoto, T Yamamoto, E Kuramoto, Y Kimura, O Yano, T Tokunaga.   

Abstract

Thirteen kinds of 45-mer or 30-mer synthetic oligonucleotides with sequences randomly selected from the cDNA encoding three kinds of protein of Mycobacterium bovis BCG were tested for their antitumor activity in a murine tumor system. Six out of the 13 single-stranded oligonucleotides which contained one or more hexameric palindromic sequences showed strong antitumor activity while the others without palindromic structure did not. Namely, repeated intralesional injections of 100 micrograms of the 6 oligonucleotides caused regression of the established tumor but the other 7 were ineffective. When tumor cells were mixed with 100 micrograms of an effective oligonucleotide and injected into mice, tumor growth was markedly suppressed. These results suggested that palindromic structure is essential for the antitumor activity of the synthetic oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582885      PMCID: PMC5918807          DOI: 10.1111/j.1349-7006.1992.tb00094.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  9 in total

1.  In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.

Authors:  S Shimada; O Yano; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1986-08

2.  Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells.

Authors:  T Tokunaga; O Yano; E Kuramoto; Y Kimura; T Yamamoto; T Kataoka; S Yamamoto
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

3.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

4.  Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12.

Authors:  J E Thole; W J Keulen; J De Bruyn; A H Kolk; D G Groothuis; L G Berwald; R H Tiesjema; J D van Embden
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

5.  Cloning of a species-specific antigen of Mycobacterium bovis.

Authors:  A J Radford; B J Duffield; P Plackett
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.

Authors:  S Shimada; O Yano; H Inoue; E Kuramoto; T Fukuda; H Yamamoto; T Kataoka; T Tokunaga
Journal:  J Natl Cancer Inst       Date:  1985-03       Impact factor: 13.506

7.  Effect of bestatin on mouse immune system and experimental murine tumors.

Authors:  M Ishizuka; T Masuda; N Kanbayashi; S Fukasawa; T Takeuchi; T Aoyagi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1980-06       Impact factor: 2.649

8.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

Authors:  T Tokunaga; H Yamamoto; S Shimada; H Abe; T Fukuda; Y Fujisawa; Y Furutani; O Yano; T Kataoka; T Sudo
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

9.  In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.

Authors:  S Yamamoto; E Kuramoto; S Shimada; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1988-07
  9 in total
  6 in total

Review 1.  Mechanisms of immune stimulation by bacterial DNA.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

Authors:  S Yamamoto; T Yamamoto; S Iho; T Tokunaga
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Antibody responses to DNA in normal immunity and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 4.  Treatment of recurrent metastatic head and neck cancer: focus on cetuximab.

Authors:  Akshar N Patel; Janice M Mehnert; Sung Kim
Journal:  Clin Med Insights Ear Nose Throat       Date:  2012-04-03

5.  Oligonucleotide sequences required for natural killer cell activation.

Authors:  E Kuramoto; O Yano; Y Kimura; M Baba; T Makino; S Yamamoto; T Yamamoto; T Kataoka; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1992-11

6.  Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro.

Authors:  T Yamamoto; S Yamamoto; T Kataoka; K Komuro; M Kohase; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1994-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.